Literature DB >> 22374401

Hemithoracic intensity-modulated radiotherapy using helical tomotherapy for patients after extrapleural pneumonectomy for malignant pleural mesothelioma.

Takeshi Ebara1, Hidemasa Kawamura, Takuya Kaminuma, Masahiko Okamoto, Daisaku Yoshida, Yu Okubo, Takeo Takahashi, Kunihiko Kobayashi, Hirozo Sakaguchi, Yoshitaka Ando, Takashi Nakano.   

Abstract

Postoperative hemithoracic irradiation is regarded as an important part of the curative treatment for resectable malignant pleural mesothelioma (MPM). Because the clinical target volume in postoperative MPM is irregular and surrounded by dose-limiting critical structures, intensity-modulated radiation therapy (IMRT) is thought to be suitable. However, postoperative hemithoracic IMRT remains experimental due to a high incidence of fatal pneumonitis. Therefore, a Phase I dose escalation study for hemithoracic IMRT using helical tomotherapy was planned, and the results of the first three patients are herein reported because this technique may provide benefits to such patients. For 3 patients with postoperative MPM, who were treated by extrapleural pneumonectomy (EPP), a radiation dose of 45.0 Gy in 25 fractions was given to cover 95% of the PTV. The lung V5s of the three patients were 14.3%, 10.0%, and 31.3%, respectively. The V5s of the present plans was smaller than that of the recent IMRT planning studies. The lung V20s of these patients were 2.4%, 2.2%, and 4.3%, respectively. Their MLDs were 4.3 Gy, 3.4 Gy, and 5.8 Gy, respectively. The follow-up periods of the patients were 26, 14 and 9 months from initiation of IMRT, respectively. All patients were alive, although local and contralateral recurrences had developed in 1 patient. Only 1 patient had Grade 2 acute esophagitis and nausea. There was no treatment-related pneumonitis. Hemithoracic IMRT using helical tomotherapy may play a crucial role in adjuvant treatment for MPM after EPP.

Entities:  

Mesh:

Year:  2012        PMID: 22374401     DOI: 10.1269/jrr.11130

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  5 in total

Review 1.  Recent advances in radiotherapy for thoracic tumours.

Authors:  Michael Fay; Christopher M Poole; Gary Pratt
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 2.  Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

Authors:  Charlotte De Bondt; Ioannis Psallidas; Paul E Y Van Schil; Jan P van Meerbeeck
Journal:  Transl Lung Cancer Res       Date:  2018-10

3.  Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.

Authors:  Christina Leitzen; Timo Wilhelm-Buchstab; Sabina Stumpf; Martina Heimann; David Koch; Christopher Schmeel; Birgit Simon; Susanne Vornholt; Stephan Garbe; Fred Röhner; Felix Schoroth; Hans Heinz Schild; Heinrich Schüller; Thomas Müdder
Journal:  Strahlenther Onkol       Date:  2019-03-26       Impact factor: 3.621

4.  Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis.

Authors:  Yunfang Liu; Tingyi Xia; Wenjun Zhang; Yongjie Zhong; Luhua Zhang; Xuan Wang; Huiming Yu
Journal:  Radiat Oncol       Date:  2013-07-25       Impact factor: 3.481

5.  Dosimetric evaluation of helical tomotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma: a planning study for dose escalation.

Authors:  Fu-Li Zhang; Na Lu; Hua-Yong Jiang; Dian-Dian Chen; Ya-Di Wang
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.